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Association of Vitamin D Deficiency with Hypertension in Uninsured Women
Abstract
Vitamin D deficiency is an epidemic in the United States. Uninsured women are at high risk due to a lower
intake of vitamin D and limited sun exposure. We examined the association between vitamin D deficiency
and hypertension in 96 uninsured women at a County Free Medical Clinic in urban Michigan.
Questionnaires were used to obtain information about demographics, medical history including
hypertension, and dietary habits. Measurements including blood pressure and serum 25(OH)D level were
also collected. Prevalence of hypertension was higher in subjects with 25(OH)D less than 50nmol/l
compared with others (85% vs. 27.3%, p = 0.014). For every 1 nmol/L decrease in serum 25(OH)D, there
was an increase in the systolic and diastolic blood pressure by 0.20 (p =0.006) and 0.13 (p =0.003) mm of
Hg respectively. These results demonstrate a high prevalence of hypertension in the vitamin D deficient,
uninsured female population.
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Abstract
Vitamin D deficiency is an epidemic in the United States. Uninsured women
are at high risk due to a lower intake of vitamin D and limited sun exposure.
We examined the association between vitamin D deficiency and hypertension in 96 uninsured women at a County Free Medical Clinic in urban Michigan. Questionnaires were used to obtain information about demographics,
medical history including hypertension, and dietary habits. Measurements
including blood pressure and serum 25(OH)D level were also collected.
Prevalence of hypertension was higher in subjects with 25(OH)D less than
50nmol/l compared with others (85% vs. 27.3%, p = 0.014). For every 1
nmol/L decrease in serum 25(OH)D, there was an increase in the systolic and
diastolic blood pressure by 0.20 (p =0.006) and 0.13 (p =0.003) mm of Hg
respectively. These results demonstrate a high prevalence of hypertension in
the vitamin D deficient, uninsured female population
Key Words: Vitamin D; Deficiency; Hypertension; uninsured; women

INTRODUCTION
According to the 2006 U.S. Census, there are now 47 million American
citizens who do not have health insurance and the number is steadily
increasing (www.urban.org). Uninsured adults are more likely than others to
have untreated or uncontrolled hypertension (Ostchega, et al, 2008; Duru et
al, 2007) and stroke (Fowler-Brown et al, 2007). Among stroke sufferers, those
without health insurance experience more neurological impairment, longer
hospital stays and higher mortality than others (Shen et al, 2007).
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We recently reported a high prevalence of vitamin D deficiency in a
group of uninsured women living in the northern United States of America
(Kakarala et al, 2007). Several lines of evidence suggest that poor vitamin D
status may be a risk factor for hypertension and stroke. People living at higher
latitudes throughout the world, where skin production of vitamin D is limited,
are at higher risk of developing hypertension than others (Rostand SG, 1997).
Several observational studies have shown inverse correlations of vitamin
D status, as determined from blood levels of 25-hydroxyvitamin D [25(OH)
D], with blood pressure or hypertension (Lind et al, 1995; Martins et al, 2007;
Forman et al, 2007). Two independent cross sectional studies from the third
National Health and Nutrition Examination Survey, reported this association
across different ethnic groups (Scragg et al, 2007; Judd et al, 2008). In one
intervention study, supplementation with calcium and vitamin D resulted in a
substantial (9%) decrease in systolic blood pressure in elderly women (Pfeifer
et al, 2001). Evidence from animal studies suggests that vitamin D may affect
blood pressure through regulation of the renin-angiotensin system (Li et al,
2004).
We conducted the present analysis to determine whether vitamin D
status in our population of uninsured women receiving their health care
at a community based free clinic is associated with blood pressure or
hypertension status. If so, this study would provide preliminary evidence
that addressing the poor vitamin D status of uninsured adults might reduce
morbidity and mortality from hypertension and stroke.

METHODS
Subjects and study design
The design and data-collection methods for this study have been
reported previously (Kakarala et al, 2007). The study was approved by the
Institutional Review Board for human subjects, and all patients gave written
informed consent to participate in the study. This is a cross-sectional study
of uninsured women aged 18 to 64 years receiving medical care from a
County Free Clinic in urban Michigan during the period of 2005 to 2006. The
exclusion criteria included known significant renal or hepatic dysfunction,
diseases associated with significant malabsorption, use of prescription
vitamin D, pregnancy, treatment with medications that interfere with vitamin
D metabolism, or substantial discrepancies between self-reported medical
status and medical record information.
Two investigators recruited the subjects three days a week using a
standardized case report form. Of the 155 eligible patients, 145 women, all
uninsured, provided written informed consent and were enrolled. Assessment
of vitamin D status required a separate laboratory visit, and 49 of the 145
enrolled patients were unwilling or unable to return for that visit. The 96
patients with known vitamin D status were included in this analysis. As
previously reported (Kakarala et al, 2007), there were no significant differences
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between the 49 women who were unwilling to return for the laboratory visit
and the 96 who were eventually enrolled with respect to race, vitamin D intake,
sun exposure and body mass index. However the enrolled subjects were an
average of 5 years older than those women that were excluded.
Measurements
Hypertension diagnosis was defined as a positive response by the
patients to a question on an administered health questionnaire. This question
asked patients whether a clinician had diagnosed hypertension in them.
The reliability of self-reported hypertension has been shown in previous
epidemiological studies (Vargas et al, 1999), but we nevertheless verified
hypertension diagnosis and treatment by review of the medical records. All
the subjects with hypertension were prescribed anti-hypertensive medications
as confirmed by chart review. They obtain their medication monthly at the
free clinic, after consultation with a physician, for proper control of their blood
pressure. Blood pressure was measured with a sphygmomanometer with an
appropriate sized cuff, after asking the subjects to sit quietly for a few minutes.
Systolic and diastolic blood pressures were taken at Korotkov sounds I and V.
Information about demographics including age, height, weight, body mass
index (BMI: calculated as weight in kilograms divided by height in meters
squared) race, health status, multivitamin, vitamin D supplementation, sunlight
exposure and dietary habits were ascertained from the health questionnaire.
Height was self-reported. A validated short food frequency screening
instrument was used to assess dietary vitamin D and calcium intakes (Blalock et
al, 2003). Serum 25(OH)D levels were measured with direct radioimmunoassay
(using a Diasorin radioimmunoassay kit) and reported as nmol/l (multiply
nmol/L by a conversion factor of 2.496 to obtain ng/ml). Vitamin D deficiency
was defined as a serum 25(OH)D concentration less than 50 nmol/L (20 ng/ml)
for consistency with a prior study in the same subjects (Kakarala et al, 2007)
and to allow for comparison of our subjects with the representative NHANES III
population (Looker et al, 2002). Serum total calcium level was measured using
standard automated calorimetric method.
Data Analysis
The biostatistical evaluation was carried out using the SPSS 14.0 statistical
package (SPSS Inc., Chicago, IL). A descriptive statistical analysis was made,
including measurements of central tendency and spread for quantitative
variables. Chi-square and student “t” tests were used to compare the variables
between different groups. Pearson correlation coefficients were calculated to
assess simple linear associations of 25(OH)D with other variables. A series of
multiple linear regression analyses were performed to describe the association
between serum 25(OH)D levels and blood pressure and to adjust for other
determinants of blood pressure (age, BMI, race, calcium intake and vitamin
D intake). A multiple logistic regression analysis was performed in order to
describe the association of 25(OH)D with hypertension after adjustment for
other variables. Statistical significance was established as a P value of 0.05.
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RESULTS
Characteristics of the study subjects
Characteristics of the 96 subjects are shown in Table 1. Subjects with
lower serum 25(OH)D levels tended to be older and have a higher BMI than
those who are non-deficient, however there was no statistically significant
difference between the groups. Vitamin D deficiency was more prevalent in
African- American women than in others, and subjects with higher serum
25(OH)D levels were consuming more calcium and vitamin D through their
diet.
Association of serum 25(OH)D with hypertension
Hypertension was present in 65% (62 out of 96) of the subjects and
its prevalence decreased across categories of increasing 25(OH)D (Table
1). Similarly, 25(OH)D was significantly lower among hypertensive than
normotensive subjects (59.4±33.2 vs. 38.9±20.8 nmol/l, P<0.001).
Table 1. Characteristics of participants (N = 96) according to the serum 25
(OH)D status. Variable values are shown as mean±SD
Variable

Serum 25(OH)D (nmol/L)
≤22.5
(n=20)

22.6 - 37.5 37.6 - 50.0 50.1 - 79.9
(n=25)
(n=19)
(n=21)

P-value
≥80.0
(n=11)

25 (OH)D*

18.4±4.4

30.1±3.8

45.3±5.7

60.5±8.4

107.2±16.0

<0.001

Age (Yrs)

51.7±9.2

47.5±8.9

51.1±9.4

46.2±13.7

46.2±13.7

0.145

BMI (Kg/m2)

34.4±6.6

31.9±9.0

35.7±7.4

31.2±9.6

30.2±7.8

0.186

SBP**

139.3±21.2

132.2±16.0

131.7±15.3

123.2±15.9

115.6±14.8

0.002

DBP**

80.1±12.4

82.5±10.4

78.2±9.7

76.3±13.2

70.7±7.7

0.053

72±56

116±111

142±102

174±131

166±119

0.029

402±174

591±373

825±595

741±420

701±382

0.019

Vitamin D¶
Calcium§
Race (n, (%))

<0.001

Caucasian

4 (20.0)

15 (60.0)

15 (79.0)

19 (90.4)

11 (100.0)

AA

13 (65.0)

6 (24.0)

2 (10.5)

0 ( 0.0)

0 ( 0.0)

Hispanic

1 ( 5.0)

2 ( 8.0)

0 ( 0.0)

1 ( 4.8)

0 ( 0.0)

NA

1 ( 5.0)

0 ( 0.0)

0 ( 0.0)

1 ( 4.8)

0 ( 0.0)

Other

1 ( 5.0)

2 ( 8.0)

2 (10.5)

0 ( 0.0)

0 ( 0.0)

17 (85.0)

17 (68.0)

14 (73.7)

11 (52.4)

3 ( 27.3)

Hypertension

0.014

*Serum 25(OH)D levels in nmol/L; BMI = Body mass index; SBP = Systolic blood pressure; DBP =
Diastolic blood pressure; **Blood pressure in mm of Hg; ¶Vitamin D intake in IU/day; §Calcium
intake in mg/day; Vitamin D and calcium intake were calculated from food questionnaires; AA =
African American; NA = Native American
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We performed logistic regression analyses in order to determine whether
this association remained after adjustment for potential confounders
including age, race, BMI and calcium intake. In this analysis, (Table 2) the odds
ratio for 25(OH)D (included as a continuous variable) was 0.96, indicating
a 4% reduction in risk of hypertension for each 1 nmol/L increase in serum
25(OH)D.
Table 2. Independent predictors of hypertension in 96 women
Variable

Odds Ratio

95% CI

P-Value

Serum 25(OH)D*

0.963

0.937 - 0.989

0.006

Age (years)

1.127

1.054 - 1.205

<0.001

BMI (Kg/m2)

1.192

1.087 - 1.307

<0.001

1.720

0.397 - 7.450

0.469

0.999

0.998 - 1.001

0.447

Race
Non-Caucasian
Caucasian (Reference Group)
Calcium Intake (mg/d)

*Serum 25(OH)D level in nmol/L, BMI = Body Mass Index
Association of serum 25(OH)D levels with blood pressure
Both systolic and diastolic blood pressure decreased across categories
of increasing serum 25(OH)D level (Table 1). There was a negative correlation
between serum 25(OH)D and blood pressure [systolic (r= -0.40, p < 0.001)
and diastolic (r= -0.31, P= 0.002)] (Figure 1). Although all the hypertensives
in this study were being treated for their condition their blood pressure
remained significantly higher than that of the normotensive subjects (136±16
vs. 117±1, P<0.001 for systolic blood pressure and 80±12 vs. 75±10, P= 0.036
for diastolic blood pressure). In order to determine whether the association
of 25(OH)D with blood pressure differed between normotensives and treated
hypertensives, we included a 25(OH)D by hypertension status interaction
term in regressions of 25(OH)D on systolic and diastolic blood pressure while
also controlling for age, race, BMI and calcium intake. The interaction terms
were not statistically significant for systolic (P=0.695) or diastolic (P=0.598)
blood pressure and were removed in subsequent regressions. The effects
of adding potential confounders as independent variables in regressions
of systolic and diastolic blood pressure on 25(OH)D are shown in table 3.
Regression coefficients for 25(OH)D in relation to systolic blood pressure
and diastolic blood pressure were -0.20 (P= 0.006) and -0.13 (p = 0.003)
respectively, after adjustment for age, BMI, race and calcium intake. In other
words, for every 1 nmol/L decrease in serum 25(OH)D, there is an increase
in the systolic and diastolic blood pressure by 0.20 and 0.13 mm of Hg
respectively.
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DISCUSSION
In our earlier paper (Kakarala et al, 2007), we reported that two thirds of
the uninsured women in our study population were vitamin D deficient as
defined by a serum 25(OH)D level less than 50 nmol/L. In the present analysis
we found that both blood pressure and the prevalence of hypertension
decreased with increasing 25(OH)D levels in this group, and these associations
were independent of age, BMI, and race. Although this association has been
observed in other populations (Foreman et al, 2007; Sowers et al, 1987), it
may be of particular importance among uninsured adults because it suggests
a potential route for preventing hypertension that is inexpensive and not
dependent on formal medical care. As we reported previously, the nonCaucasian women in this study, most of whom were African-American, were
three times more likely than Caucasian women to have 25(OH)D levels under
50 nmol/L (Kakarala et al, 2007). Scragg et al (2007), recently reported that
racial differences in 25(OH)D explained about half the increased hypertension
prevalence of black compared with white participants in NHANES III. Judd et
al (2008), analyzed the NHANES III data somewhat differently and reported
a significant interaction of race with 25(OH)D indicating no association of
25(OH)D with blood pressure in blacks (Judd et al 2008). More work is needed
to fully understand the contribution of poor vitamin D status to increased
hypertension in blacks, particularly because most observational studies,
including ours, lacked sufficient numbers of black participants with high
25(OH)D concentrations to fully explore the benefit of vitamin D repletion
in this group. However, given the mounting evidence of a role for vitamin D
in preventing numerous chronic and infectious diseases, many of which are
more prevalent in persons of color (Harris et al 2006), improving the poor
vitamin D status of African-Americans should be an important public health
priority.
The finding of an inverse association between 25(OH) D and blood
pressure, in our study, supports the cumulative evidence of various
epidemiological and clinical data from the past decade. Animal model studies
demonstrate that vitamin D is a negative endocrine inhibitor of the reninangiotensin II system and plays a role in the regulation of blood pressure and
volume homeostasis (Li et al, 2004). A recent study by Zhou et al also showed
that 1,25(OH)2D might play an important role in cardiovasular health by
repressing the renin-angiotensin system, independent of extracellular calcium
or phosphorus ( Zhou C et al, 2008).
Intervention studies are needed to establish a firm causal link between
vitamin D status and hypertension. However, given the growing evidence
of widespread vitamin D deficiency (Looker et al, 2002) and its association
with numerous chronic conditions (Holick et al, 2007) and increased mortality
(Melamed et al, 2008), it is not premature to encourage uninsured individuals,
like others, to increase their vitamin D intake. Although the optimal 25(OH)
D concentration to prevent hypertension is unknown, a level of at least 75-
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80 nmol/L is considered optimal for multiple health outcomes (Holick et al,
2007; Bischoff-Ferrari HA et al, 2008). Most experts now feel that 1000 IU/d or
more are needed for adults in northern areas to maintain adequate vitamin
D levels year round (Dawson-Hughes et al, 2005; Holick et al, 2008), much
more than the 100-200 IU/d consumed by most of our subjects. The safety
of doses as high as or higher than 1000 IU/d is well established (Vieth et al,
2007). In summary, the prevention and treatment of vitamin D deficiency
may be one way to reduce the risk for and consequences of hypertension in
the vulnerable uninsured population.

CONCLUSIONS
These results demonstrate a high prevalence of hypertension in a vitamin
D deficient, uninsured, medically underserved female population. Uninsured
women should be strongly encouraged to increase their vitamin D intake
to control their hypertension, along with therapeutic lifestyle changes and
medications.
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